About
Precede develops a platform that uses genome-wide transcriptional analysis of cell-free DNA from blood to provide real-time insights into disease mechanisms, supporting precision medicine and drug development.
Explore Precede's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.